Morgans Senior Analyst Scott Power, and Research Analyst Iain Wilkie close the week with another episode of Under the microscope. In this episode, the boys comment on key movements in the healthcare space including Iains comments on the latest in the Medical Cannabis space. Featured companies include Volpara (ASX:VHT), Pro Medicus (ASX:PME), Mach7 (ASX:M7T), Cann Group (ASX:CAN), THC Global Group (ASX:THC), Zelira Therapeutics (ASX:ZLD), Antisense Therapeutics (ASXANP) and the newly consolidated Opal Horizon (ASX:OHZ). Listen to the full podcast here!